Peptide therapy at Stryker Optimal Health and Wellness may include FDA-approved medications as well as compounded peptides that are not FDA-approved for specific medical indications. Some peptides are prescribed off-label. Compounded peptides are obtained from U.S.-based pharmacies that operate under applicable federal and state regulations, including 503A and 503B compounding standards. Peptide therapy is elective and is not considered standard medical care. Safety, dosing, and long-term effects may vary based on the specific peptide and individual response. All patients complete a medical evaluation and review informed consent prior to starting treatment. FDA Status and Use Some peptides used in wellness and performance care do not have FDA approval for specific medical indications. FDA approval requires extensive clinical trials, which may not be completed for all peptides due to limited commercial sponsorship. Lack of FDA approval means the FDA has not reviewed sufficient evidence to determine safety or effectiveness for that specific use. Pharmacy and Compounding Standards Compounded peptides are sourced from U.S. based pharmacies operating under applicable federal and state regulations, including 503A and 503B compounding standards. These pharmacies follow requirements related to manufacturing, testing, and dispensing compounded medications. Stryker Optimal Health and Wellness does not prescribe or dispense research chemicals or products intended solely for laboratory use. Safety Considerations For certain peptides, sufficient long term safety data may be limited. Safety, dosing, and long term effects may vary based on the specific peptide, route of administration, and individual response. Medical Oversight Peptide therapy is elective and not considered standard medical care. All patients complete a medical evaluation and are required to review and sign informed consent prior to starting treatment. Peptide therapy is not a substitute for medical care, physical therapy, or lifestyle interventions.